Neurocrine Biosciences, Inc. - stock earnings
NBIX Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 1, 2024 AfterMarket | 0.42 / 1.03 | - | 515.3 million / 523.9 million | - |
| July 30, 2024 BeforeMarket | - / - | 532.9 million | - / 548.0 million | 581.0 million |
NBIX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q1 | 43.4 million USD | 515.3 million USD |
| 2023Q4 | 147.7 million USD | 515.2 million USD |
| 2023Q3 | 83.1 million USD | 498.8 million USD |
| 2023Q2 | 95.5 million USD | 452.7 million USD |
| 2023Q1 | -76.6 million USD | 420.4 million USD |
| 2022Q4 | 89.0 million USD | 412.0 million USD |
| 2022Q3 | 68.5 million USD | 387.9 million USD |
| 2022Q2 | -16.9 million USD | 378.2 million USD |
| 2022Q1 | 13.9 million USD | 310.6 million USD |
| 2021Q4 | -7.3 million USD | 312.0 million USD |
| 2021Q3 | 22.5 million USD | 296.0 million USD |
| 2021Q2 | 42.3 million USD | 288.9 million USD |
| 2021Q1 | 32.1 million USD | 236.6 million USD |
| 2020Q4 | 347.9 million USD | 247.9 million USD |
| 2020Q3 | -57.6 million USD | 258.5 million USD |
| 2020Q2 | 79.6 million USD | 302.4 million USD |
| 2020Q1 | 37.4 million USD | 237.1 million USD |
| 2019Q4 | 34.0 million USD | 244.1 million USD |
| 2019Q3 | 53.8 million USD | 222.1 million USD |
| 2019Q2 | 51.3 million USD | 183.6 million USD |
| 2019Q1 | -102.1 million USD | 138.4 million USD |
| 2018Q4 | 18.1 million USD | 131.5 million USD |
| 2018Q3 | 50.8 million USD | 151.8 million USD |
| 2018Q2 | -5.9 million USD | 96.9 million USD |
| 2018Q1 | -41.8 million USD | 71.1 million USD |
| 2017Q4 | 6.9 million USD | 94.5 million USD |
| 2017Q3 | -11.1 million USD | 60.8 million USD |
| 2017Q2 | -60.0 million USD | 6.3 million USD |
| 2017Q1 | -78.3 million USD | ? USD |
| 2016Q4 | -44.7 million USD | 15.0 million USD |
| 2016Q3 | -36.9 million USD | 15.0 million USD |
| 2016Q2 | -40.3 million USD | 30.0 million USD |
| 2016Q1 | -19.3 million USD | 15.0 million USD |
| 2015Q4 | -29.3 million USD | 19.8 million USD |
| 2015Q3 | -34.4 million USD | ? USD |
| 2015Q2 | -24.0 million USD | 19.8 million USD |
| 2015Q1 | -1.2 million USD | 19.8 million USD |
| 2014Q4 | -19.4 million USD | ? USD |
| 2014Q3 | -15.9 million USD | ? USD |
| 2014Q2 | -13.4 million USD | ? USD |
| 2014Q1 | -11.8 million USD | ? USD |
| 2013Q4 | -10.6 million USD | 730000 USD |
| 2013Q3 | -11.1 million USD | 729000 USD |
| 2013Q2 | -12.2 million USD | 730000 USD |
| 2013Q1 | -12.1 million USD | 730000 USD |
| 2012Q4 | 9.5 million USD | 21.9 million USD |
| 2012Q3 | -3.1 million USD | 9.4 million USD |
| 2012Q2 | -501000 USD | 10.6 million USD |
| 2012Q1 | -886000 USD | 11.3 million USD |
| 2011Q4 | 1.3 million USD | 11.1 million USD |
| 2011Q3 | 31.4 million USD | 41.6 million USD |
| 2011Q2 | 2.0 million USD | 12.2 million USD |
| 2011Q1 | 2.9 million USD | 12.5 million USD |
| 2010Q4 | 2.5 million USD | 13.7 million USD |
| 2010Q3 | 3.3 million USD | 14.4 million USD |
| 2010Q2 | -5.2 million USD | 4.6 million USD |
| 2010Q1 | -8.6 million USD | 753000 USD |
| 2009Q4 | -7.9 million USD | 740000 USD |
| 2009Q3 | -8.2 million USD | 733000 USD |
| 2009Q2 | -15.3 million USD | 733000 USD |
| 2009Q1 | -19.7 million USD | 747000 USD |
| 2008Q4 | -28.9 million USD | 729000 USD |
| 2008Q3 | -17.7 million USD | 761000 USD |
| 2008Q2 | -21.0 million USD | 734000 USD |
| 2008Q1 | -21.1 million USD | 1.8 million USD |
| 2007Q4 | -128.0 million USD | 532000 USD |
| 2007Q3 | -27.2 million USD | 540000 USD |
| 2007Q2 | -26.4 million USD | 48000 USD |
| 2007Q1 | -25.7 million USD | 104000 USD |
| 2006Q4 | -14.7 million USD | 9.4 million USD |
| 2006Q3 | -39.1 million USD | 1.1 million USD |
| 2006Q2 | -27.4 million USD | 9.2 million USD |
| 2006Q1 | -25.9 million USD | 19.5 million USD |
| 2005Q4 | -23.9 million USD | 14.1 million USD |
| 2005Q3 | 26.2 million USD | 64.7 million USD |
| 2005Q2 | -5.6 million USD | 33.2 million USD |
| 2005Q1 | -18.8 million USD | 11.9 million USD |
| 2004Q4 | -20.6 million USD | 18.5 million USD |
| 2004Q3 | -1.6 million USD | 34.7 million USD |
| 2004Q2 | -11.1 million USD | 15.0 million USD |
| 2004Q1 | -12.4 million USD | 16.9 million USD |
| 2003Q4 | 3.2 million USD | 27.1 million USD |
| 2003Q3 | -9.8 million USD | 29.3 million USD |
| 2003Q2 | -10.2 million USD | 45.0 million USD |
| 2003Q1 | -13.4 million USD | 37.7 million USD |
| 2002Q4 | -38.8 million USD | 3.9 million USD |
| 2002Q3 | -20.2 million USD | 5.0 million USD |
| 2002Q2 | -19.8 million USD | 4.2 million USD |
| 2002Q1 | -15.8 million USD | 5.0 million USD |
| 2001Q4 | -14.6 million USD | 12.8 million USD |
| 2001Q3 | 2.5 million USD | 21.6 million USD |
| 2001Q2 | -13.3 million USD | 3.3 million USD |
| 2001Q1 | -11.5 million USD | 3.5 million USD |
| 2000Q4 | -9.4 million USD | 3.5 million USD |
| 2000Q3 | -8.1 million USD | 5.3 million USD |
| 2000Q2 | -5.2 million USD | 2.9 million USD |
| 2000Q1 | -6.0 million USD | 2.8 million USD |
| 1999Q4 | -3.7 million USD | 4.2 million USD |
| 1999Q3 | -4.4 million USD | 5.2 million USD |
| 1999Q2 | -4.6 million USD | 3.8 million USD |
| 1999Q1 | -4.1 million USD | 3.6 million USD |
| 1998Q4 | -6.8 million USD | 4.5 million USD |
| 1998Q3 | -4.0 million USD | 5.1 million USD |
| 1998Q2 | -8.0 million USD | 2.3 million USD |
| 1998Q1 | -1.2 million USD | 6.2 million USD |
| 1997Q4 | ? USD | 6.2 million USD |
| 1997Q3 | 800000 USD | 6.2 million USD |
| 1997Q2 | 100000 USD | 4.8 million USD |
| 1997Q1 | 4.1 million USD | 8.9 million USD |
| 1996Q4 | 4.5 million USD | 9.3 million USD |
| 1996Q3 | -400000 USD | 2.2 million USD |
| 1996Q2 | 1.8 million USD | 5.5 million USD |
| 1996Q1 | ? USD | 2.2 million USD |
NBIX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 249.7 million USD | 1.9 billion USD |
| 2022 | 154.5 million USD | 1.5 billion USD |
| 2021 | 89.6 million USD | 1.1 billion USD |
| 2020 | 407.3 million USD | 1.0 billion USD |
| 2019 | 37.0 million USD | 788.1 million USD |
| 2018 | 21.1 million USD | 451.2 million USD |
| 2017 | -142.5 million USD | 161.6 million USD |
| 2016 | -141.1 million USD | 15.0 million USD |
| 2015 | -88.9 million USD | 19.8 million USD |
| 2014 | -60.5 million USD | ? USD |
| 2013 | -46.1 million USD | 2.9 million USD |
| 2012 | 5.0 million USD | 53.1 million USD |
| 2011 | 37.6 million USD | 77.4 million USD |
| 2010 | -8.0 million USD | 33.5 million USD |
| 2009 | -51.0 million USD | 3.0 million USD |
| 2008 | -88.6 million USD | 4.0 million USD |
| 2007 | -207.3 million USD | 1.2 million USD |
| 2006 | -107.2 million USD | 39.2 million USD |
| 2005 | -22.2 million USD | 123.9 million USD |
| 2004 | -45.8 million USD | 85.2 million USD |
| 2003 | -30.3 million USD | 139.1 million USD |
| 2002 | -94.5 million USD | 18.0 million USD |
| 2001 | -36.9 million USD | 41.2 million USD |
| 2000 | -28.8 million USD | 14.6 million USD |
| 1999 | -16.8 million USD | 16.8 million USD |
| 1998 | -20.0 million USD | 16.0 million USD |
| 1997 | 5.1 million USD | 26.1 million USD |
| 1996 | 5.9 million USD | 19.2 million USD |
NBIX
Price: $140.08
52 week price:
Earnings Per Share: 2.47 USD
P/E Ratio: 53.35
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 490000
Ebitda: 15.0 millionMarket Capitalization: 14.4 billion